Abstract

You have accessJournal of UrologyModerated Poster, Sunday, May 22, 2005, 1:00 - 3:00 pm1 Apr 2005454: RM2 Antigen (Beta 1,4-Galnac-Disialyl-LC4) as a New Marker for Prostate Cancer Seiichi Saito, Shin Egawa, Mareyuki Endoh, Seiji Ueno, Akihiro Ito, Kenji Numahata, Makoto Satoh, Sadahito Kuwao, Shiro Baba, Yoichi Arai, and Senitiroh Hakomori Seiichi SaitoSeiichi Saito More articles by this author , Shin EgawaShin Egawa More articles by this author , Mareyuki EndohMareyuki Endoh More articles by this author , Seiji UenoSeiji Ueno More articles by this author , Akihiro ItoAkihiro Ito More articles by this author , Kenji NumahataKenji Numahata More articles by this author , Makoto SatohMakoto Satoh More articles by this author , Sadahito KuwaoSadahito Kuwao More articles by this author , Shiro BabaShiro Baba More articles by this author , Yoichi AraiYoichi Arai More articles by this author , and Senitiroh HakomoriSenitiroh Hakomori More articles by this author View All Author Informationhttps://doi.org/10.1016/S0022-5347(18)34707-4AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail "454: RM2 Antigen (Beta 1,4-Galnac-Disialyl-LC4) as a New Marker for Prostate Cancer." The Journal of Urology, 173(4S), p. 124 © 2016 by American Urological AssociationFiguresReferencesRelatedDetails Volume 173Issue 4SApril 2005Page: 124 Advertisement Copyright & Permissions© 2016 by American Urological AssociationMetricsAuthor Information Seiichi Saito More articles by this author Shin Egawa More articles by this author Mareyuki Endoh More articles by this author Seiji Ueno More articles by this author Akihiro Ito More articles by this author Kenji Numahata More articles by this author Makoto Satoh More articles by this author Sadahito Kuwao More articles by this author Shiro Baba More articles by this author Yoichi Arai More articles by this author Senitiroh Hakomori More articles by this author Expand All Advertisement PDF downloadLoading ...

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call